$
138.260
-0.46(-0.332%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
139.480
Open
138.890
VWAP
138.68
Vol
153.06K
Mkt Cap
9.14B
Low
138.110
Amount
21.23M
EV/EBITDA(TTM)
12.66
Total Shares
66.26M
EV
10.07B
EV/OCF(TTM)
16.35
P/S(TTM)
2.60
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. It also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.
Show More
AI Stock Picker

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
959.45M
+8.13%
1.420
+18.33%
905.80M
+6.81%
1.432
-5.81%
951.32M
+4.62%
1.570
+5.37%
Estimates Revision
The market is revising Downward the revenue expectations for AptarGroup, Inc. (ATR) for FY2025, with the revenue forecasts being adjusted by -0.33% over the past three months. During the same period, the stock price has changed by -12.54%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.33%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.57%
In Past 3 Month
Stock Price
Go Down
down Image
-12.54%
In Past 3 Month
4 Analyst Rating
up
Wall Street analysts forecast ATR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATR is 167.33 USD with a low forecast of 153.00 USD and a high forecast of 177.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
up
Current: 138.260
sliders
Low
153.00
Averages
167.33
High
177.00
Wells Fargo
Gabe Hajde
Overweight
downgrade
$173 -> $153
2025-08-04
Reason
Wells Fargo analyst Gabe Hajde lowered the firm's price target on AptarGroup to $153 from $173 and keeps an Overweight rating on the shares. The firm notes Q2 results were strong, though driving shares lower Friday were the Q3 guide, litigation cost headwinds and normalizing growth of a key pharma product. With these items now looking priced in, next catalyst is the September Investor Day, Wells adds.
Raymond James
Matt Roberts
Outperform
to
Outperform
downgrade
$182 -> $172
2025-08-04
Reason
Raymond James analyst Matt Roberts lowered the firm's price target on AptarGroup to $172 from $182 and keeps an Outperform rating on the shares. Aptar's defensible moats and fortress balance sheet, coupled with a specialty and growing position in Pharma end markets, make it a high-quality compounder story long-term, the analyst tells investors in a research note. The firm expects Pharma core sales to decelerate in Q3 and continues to expect Pharma core sales in 2025 to be below the 7%-11% long term target, but says that an improving mix and continued benefit from royalty revenue continues to drive strong margin performance, and the prior build-out of Injectables capacity is showing strong returns in higher margin Injectables components.
Wells Fargo
Overweight
maintain
$170 -> $173
2025-07-18
Reason
Wells Fargo raised the firm's price target on AptarGroup to $173 from $170 and keeps an Overweight rating on the shares. The firm notes that while calendar Q2 started with high uncertainty for the Packaging & Containers industry, results tracked largely in line with expectations, with FX a boost to those exposed. Beverage cans are likely strongest performers, while "value seeking behavior" a key headwind, Wells adds.
Raymond James
Outperform
maintain
$175 -> $182
2025-07-15
Reason
Raymond James raised the firm's price target on AptarGroup to $182 from $175 and keeps an Outperform rating on the shares. Sentiment on Packaging names under coverage into their earnings reports remains tepid with the group underperforming the S&P 500 to date, the analyst tells investors in a research note. The firm expects Q2 reports to be broadly in line and 2025 guidance intact, albeit "shades" of caution for the second half of 2025.
Raymond James
Matt Roberts
Buy
Maintains
$190 → $175
2025-04-22
Reason
Raymond James lowered the firm's price target on AptarGroup to $175 from $190 and keeps an Outperform rating on the shares. The firm revised estimates for Packaging companies under coverage ahead of earnings with its estimate updates generally taking a more conservative volume approach as consumer trends starting in Q2 have sounded lackluster at best, the analyst tells investors in a research note. Based on the firm's stress test, Raymond James sees ~10%-20% downside to EPS estimates in a recession scenario.
Baird
Ghansham Panjabi
Buy
Maintains
$185 → $160
2025-02-10
Reason
Baird analyst Ghansham Panjabi lowered the firm's price target on AptarGroup to $160 from $185 and keeps an Outperform rating on the shares. The firm said they see near-term headwinds but the long sterm story remains intact.

Valuation Metrics

The current forward P/E ratio for Aptargroup Inc (ATR.N) is 22.83, compared to its 5-year average forward P/E of 28.23. For a more detailed relative valuation and DCF analysis to assess Aptargroup Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
28.23
Current PE
22.83
Overvalued PE
31.87
Undervalued PE
24.60

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
13.63
Current EV/EBITDA
12.04
Overvalued EV/EBITDA
14.86
Undervalued EV/EBITDA
12.41

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
2.48
Current PS
2.38
Overvalued PS
2.79
Undervalued PS
2.17
Financial AI Agent

Financials

Annual
Quarterly
FY2025Q2
YoY :
+6.15%
966.01M
Total Revenue
FY2025Q2
YoY :
+13.90%
146.32M
Operating Profit
FY2025Q2
YoY :
+23.52%
111.73M
Net Income after Tax
FY2025Q2
YoY :
+24.63%
1.67
EPS - Diluted
FY2025Q2
YoY :
-19.07%
61.00M
Free Cash Flow
FY2025Q2
YoY :
+0.82%
30.76
Gross Profit Margin - %
FY2025Q2
YoY :
+4.19%
9.46
FCF Margin - %
FY2025Q2
YoY :
+16.40%
11.57
Net Margin - %
FY2025Q2
YoY :
+15.13%
11.72
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
1.1M
USD
3
3-6
Months
7.3M
USD
7
6-9
Months
0.0
USD
0
0-12
Months
7.0M
USD
7
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 17075% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
435.1K
Volume
4
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
2
281.7K
Volume
Months
6-9
1
1.6K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
2
16.0K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Intellectia AI SwingMax

ATR News & Events

Events Timeline

2025-07-31 (ET)
2025-07-31
17:03:25
AptarGroup sees Q3 EPS $1.53-$1.61, consensus $1.65
select
2025-07-31
17:02:38
AptarGroup reports Q2 EPS $1.67, consensus $1.59
select
2025-07-15 (ET)
2025-07-15
17:07:23
AptarGroup acquires Mod3 Pharma's clinical trial manufacturing capabilities
select
Sign Up For More Events

News

9.5
08-05NASDAQ.COM
AptarGroup (ATR) Q2 2025 Earnings Call Transcript
9.5
08-01NASDAQ.COM
AptarGroup (ATR) Q2 Revenue Rises 6%
3.0
08-01NASDAQ.COM
Relative Strength Alert For AptarGroup
Sign Up For More News

FAQ

arrow icon

What is Aptargroup Inc (ATR) stock price today?

The current price of ATR is 138.26 USD — it has decreased -0.33 % in the last trading day.

arrow icon

What is Aptargroup Inc (ATR)'s business?

arrow icon

What is the price predicton of ATR Stock?

arrow icon

What is Aptargroup Inc (ATR)'s revenue for the last quarter?

arrow icon

What is Aptargroup Inc (ATR)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Aptargroup Inc (ATR)'s fundamentals?

arrow icon

How many employees does Aptargroup Inc (ATR). have?

arrow icon

What is Aptargroup Inc (ATR) market cap?